Application 217202

Type
NDA
Sponsor
AOP HLTH US

Application Products#

Product, Drug, Ingredient table
ProductDrugIngredientFormStrengthReference drugReference standard
001RAPIBLYKLANDIOLOL HYDROCHLORIDEPOWDER;INTRAVENOUSEQ 280MG BASE/VIALYesYes

Documents#

Document, Submission type, Date table
DocumentSubmission typeDate
85072SUPPL 2026-02-18
85057SUPPL 2026-02-18
80659ORIG 2024-12-20
80426ORIG 2024-11-26
80329ORIG 2024-11-25